Highland Capital Management (Texas)’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Highland Capital Management (Texas)’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-15,000	Closed	-$315K	–	351
2018 Q4	$315K	Hold	15,000	–	–	0.02%	229
2018 Q3	$581K	Buy	15,000 +5,000	+50%	+$185K	0.03%	203
2018 Q2	$394K	Buy	+10,000	New	+$294K	0.02%	236
2017 Q4	–	Sell	-52,500	Closed	-$997K	–	347
2017 Q3	$997K	Buy	+52,500	New	+$962K	0.04%	190

Other funds holding DCPH

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highland Capital Management (Texas)'s DCPH Position: Q1 2019 in Review

Highland Capital Management (Texas) sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2019, closing a stake of 15,000 shares — an estimated $315K sold.

Highland Capital Management (Texas) first reported a position in DCPH in Q3 2017 and held it in 4 quarters. The position peaked at $997K in Q3 2017. 80 funds tracked by Wall St. Rank hold DCPH as of Q1 2019.

Highland Capital Management (Texas) reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Highland Capital Management (Texas) sold 15,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2019, an estimated $315K.
Highland Capital Management (Texas) first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
Highland Capital Management (Texas)'s Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $997K in Q3 2017.
80 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2019, filed 15 May 2019.